{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T16:30:20Z","timestamp":1776789020361,"version":"3.51.2"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.cbi.2025.111393","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T08:21:02Z","timestamp":1737447662000},"page":"111393","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Prostate cancer-selective anticancer action of an oxindole derivative via HO-1-mediated disruption of metabolic reprogramming"],"prefix":"10.1016","volume":"408","author":[{"given":"Kalpana","family":"Ghimire","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2636-510X","authenticated-orcid":false,"given":"Bhuwan Prasad","family":"Awasthi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiran","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiwoo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyunjin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7814-6638","authenticated-orcid":false,"given":"Byeong-Seon","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0824-8532","authenticated-orcid":false,"given":"Jung-Ae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2025.111393_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-020-00243-0","article-title":"Prostate cancer","volume":"7","author":"Rebello","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.cbi.2025.111393_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer statistics, 2021. CA","volume":"71","author":"Siegel","year":"2021","journal-title":"Cancer J Clin"},{"key":"10.1016\/j.cbi.2025.111393_bib3","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.cbi.2025.111393_bib4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg effect: how does it benefit cancer cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.cbi.2025.111393_bib5","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.cbi.2025.111393_bib6","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.gde.2008.02.003","article-title":"Brick by brick: metabolism and tumor cell growth","volume":"18","author":"DeBerardinis","year":"2008","journal-title":"Curr Opin Gen Dev"},{"key":"10.1016\/j.cbi.2025.111393_bib7","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0968-0004(98)01344-9","article-title":"Oncogenic alterations of metabolism","volume":"24","author":"Dang","year":"1999","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.cbi.2025.111393_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/2789_2008_088","article-title":"The interplay between MYC and HIF in the Warburg effect","author":"Dang","year":"2008","journal-title":"Oncogenes Meet Metabolism"},{"key":"10.1016\/j.cbi.2025.111393_bib9","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s42255-018-0002-y","article-title":"Mitochondrial pyruvate import is a metabolic vulnerability in androgen receptor-driven prostate cancer","volume":"1","author":"Bader","year":"2019","journal-title":"Nat. Metab."},{"key":"10.1016\/j.cbi.2025.111393_bib10","article-title":"Comparative study of serum zinc concentrations in benign and malignant prostate disease: a Systematic Review and Meta-Analysis","volume":"6","author":"Zhao","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2025.111393_bib11","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3390\/ijms21020667","article-title":"Advances of zinc signaling studies in prostate cancer","volume":"21","author":"Li","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2025.111393_bib12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1476-4598-4-32","article-title":"hZIP1 zinc uptake transporter down regulation and zinc depletion in prostate cancer","volume":"4","author":"Franklin","year":"2005","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cbi.2025.111393_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1476-4598-5-17","article-title":"The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots","volume":"5","author":"Costello","year":"2006","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cbi.2025.111393_bib14","article-title":"The emerging role of zinc transporters in cellular homeostasis and cancer","volume":"2","author":"Bafaro","year":"2017","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.cbi.2025.111393_bib15","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.mam.2012.05.008","article-title":"The SLC30 family of zinc transporters \u2013 a review of current understanding of their biological and pathophysiological roles","volume":"34","author":"Huang","year":"2013","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.cbi.2025.111393_bib16","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.jinorgbio.2004.02.005","article-title":"Metallothionein can function as a chaperone for zinc uptake transport into prostate and liver mitochondria","volume":"98","author":"Costello","year":"2004","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.cbi.2025.111393_bib17","article-title":"Hypoxia-inducible factor in cancer: from pathway regulation to therapeutic opportunity","volume":"3","author":"Brian","year":"2024","journal-title":"BMJ Oncology"},{"key":"10.1016\/j.cbi.2025.111393_bib18","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.3390\/ijms25063313","article-title":"A molecular perspective on HIF-1\u03b1 and angiogenic stimulator networks and their role in solid tumors: an update","volume":"25","author":"Magar","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2025.111393_bib19","first-page":"1936","article-title":"Expression of hypoxia-inducible factor 1alpha in human normal, benign, and malignant prostate tissue","volume":"116","author":"Du","year":"2003","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.cbi.2025.111393_bib20","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1101\/gad.1529107","article-title":"The transcription factor HIF-1 plays a critical role in the growth factor-dependent regulation of both aerobic and anaerobic glycolysis","volume":"21","author":"Lum","year":"2007","journal-title":"Genes Dev."},{"key":"10.1016\/j.cbi.2025.111393_bib21","doi-asserted-by":"crossref","first-page":"9262","DOI":"10.3390\/cimb45110580","article-title":"Interaction and collaboration of SP1, HIF-1, and MYC in regulating the expression of cancer-related genes to further enhance anticancer drug development","volume":"45","author":"Kimura","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.cbi.2025.111393_bib22","first-page":"205","article-title":"Molecular characterization and chromosomal localization of a third alpha-class hypoxia inducible factor subunit, HIF3alpha","volume":"7","author":"Gu","year":"1998","journal-title":"Gene Expr."},{"key":"10.1016\/j.cbi.2025.111393_bib23","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nrurol.2013.110-c2","article-title":"Normoxic regulation of HIF-1\u03b1 in prostate cancer","volume":"11","author":"Ranasinghe","year":"2014","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.cbi.2025.111393_bib24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1530\/JME-13-0090","article-title":"Hypoxia upregulates the gene expression of mitochondrial aconitase in prostate carcinoma cells","volume":"51","author":"Tsui","year":"2013","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.cbi.2025.111393_bib26","doi-asserted-by":"crossref","first-page":"13373","DOI":"10.1073\/pnas.1404848111","article-title":"Direct regulation of GAS6\/AXL signalling by HIF promotes renal metastasis through SRC and MET","volume":"111","author":"Rankin","year":"2014","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.cbi.2025.111393_bib27","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2023868118","article-title":"Targeting Axl favours an antitumorigenic microenvironment that enhances immunotherapy responses by decreasing Hif-1\u03b1 levels","volume":"118","author":"Goyette","year":"2021","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.cbi.2025.111393_bib28","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/j.bbamcr.2008.05.008","article-title":"Ubiquitin\u2013proteasome system mediates heme oxygenase-1 degradation through endoplasmic reticulum-associated degradation pathway","volume":"1783","author":"Lin","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cbi.2025.111393_bib29","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41392-023-01679-y","article-title":"Cellular zinc metabolism and zinc signalling: from biological functions to diseases and therapeutic targets","volume":"9","author":"Chen","year":"2024","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.cbi.2025.111393_bib30","doi-asserted-by":"crossref","first-page":"966","DOI":"10.3390\/antiox10060966","article-title":"Modulates aerobic glycolysis through LDH in prostate cancer cells","volume":"10","author":"Cascardo","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.cbi.2025.111393_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115274","article-title":"Antitumour effect of 3-(quinolin-2-ylmethylene)-4,6-dimethyl-5-hydroxy-7-azaoxindole downregulating the Gas6-Axl axis","volume":"251","author":"Bae","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2025.111393_bib31","doi-asserted-by":"crossref","first-page":"672","DOI":"10.2174\/092986710790416263","article-title":"Inhibitors of lactate dehydrogenase isoforms and their therapeutic potentials","volume":"17","author":"Granchi","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.cbi.2025.111393_bib32","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.2147\/CMAR.S161762","article-title":"The association of HIF-1\u03b1 expression with clinicopathological significance in prostate cancer: a meta-analysis","volume":"10","author":"Huang","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.cbi.2025.111393_bib33","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.tips.2012.01.005","article-title":"Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy","volume":"33","author":"Semenza","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.cbi.2025.111393_bib34","doi-asserted-by":"crossref","first-page":"21021","DOI":"10.1074\/jbc.270.36.21021","article-title":"Hypoxic Regulation of Lactate Dehydrogenase A: interaction between hypoxia-inducible factor 1 and cAMP response element","volume":"270","author":"Firth","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2025.111393_bib35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.canlet.2012.03.013","article-title":"Inhibition of LDH-A by lentivirus-mediated small interfering RNA suppresses intestinal-type gastric cancer tumorigenicity through the downregulation of Oct4","volume":"321","author":"Zhang","year":"2012","journal-title":"Cancer lett"},{"key":"10.1016\/j.cbi.2025.111393_bib36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/bpa.12299","article-title":"The regulation and function of lactate dehydrogenase A: therapeutic potential in brain tumor","volume":"26","author":"Valvona","year":"2016","journal-title":"Brain Pathol."},{"key":"10.1016\/j.cbi.2025.111393_bib37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.vph.2015.09.004","article-title":"HO-1\/CO system in tumor growth, angiogenesis and metabolism \u2014 targeting HO-1 as an anti-tumour therapy","volume":"74","author":"Loboda","year":"2015","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.cbi.2025.111393_bib38","doi-asserted-by":"crossref","first-page":"L1029","DOI":"10.1152\/ajplung.2000.279.6.L1029","article-title":"Heme oxygenase: colors of defense against cellular stress","volume":"279","author":"Otterbein","year":"2000","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.cbi.2025.111393_bib39","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1158\/1541-7786.MCR-08-0325","article-title":"Critical role of endogenous heme oxygenase 1 as a tuner of the invasive potential of prostate cancer cells","volume":"7","author":"Gueron","year":"2009","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.cbi.2025.111393_bib40","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.urology.2009.08.024","article-title":"Expression and localization of hypoxia proteins in prostate cancer: prognostic implications after radical prostatectomy","volume":"75","author":"Jans","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.cbi.2025.111393_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.658315","article-title":"The diverse roles of heme oxygenase-1 in tumor progression","volume":"12","author":"Luu Hoang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cbi.2025.111393_bib42","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","article-title":"Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies","volume":"9","author":"Zhou","year":"2024","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.cbi.2025.111393_bib43","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1089\/ars.2019.7991","article-title":"Regulation of the expression of heme oxygenase-1: signal transduction, gene promoter activation, and beyond","volume":"32","author":"Medina","year":"2019","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.cbi.2025.111393_bib44","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1089\/ars.2013.5667","article-title":"Heme oxygenase-1: a metabolic nike","volume":"20","author":"Wegiel","year":"2013","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.cbi.2025.111393_bib45","doi-asserted-by":"crossref","first-page":"9030","DOI":"10.1074\/jbc.M511397200","article-title":"The plasma membrane lactate transporter MCT4, but not MCT1, is upregulated by hypoxia through a HIF-1\u03b1-dependent mechanism","volume":"281","author":"Ullah","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2025.111393_bib46","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.celrep.2016.04.029","article-title":"Metabolic symbiosis enables adaptive resistance to anti-angiogenic therapy that is dependent on mTOR signalling","volume":"15","author":"Allen","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.cbi.2025.111393_bib47","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1042\/bj3500219","article-title":"The low-affinity monocarboxylate transporter MCT4 is adapted to the export of lactate in highly glycolytic cells","volume":"350","author":"Dimmer","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.cbi.2025.111393_bib48","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1158\/0008-5472.CAN-13-2034","article-title":"Blocking lactate export by inhibiting the Myc target MCT1 Disables glycolysis and glutathione synthesis","volume":"74","author":"Doherty","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.cbi.2025.111393_bib49","doi-asserted-by":"crossref","first-page":"21797","DOI":"10.1074\/jbc.C000023200","article-title":"Deregulation of glucose transporter 1 and glycolytic gene expression by c-myc","volume":"275","author":"Osthus","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2025.111393_bib50","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/1471-2407-11-312","article-title":"Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer","volume":"11","author":"P\u00e9rtega-Gomes","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cbi.2025.111393_bib51","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/path.4547","article-title":"A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy","volume":"236","author":"Pertega-Gomes","year":"2015","journal-title":"J. Pathol."},{"key":"10.1016\/j.cbi.2025.111393_bib52","article-title":"Targeting lactate production and efflux in prostate cancer","volume":"1866","author":"Pereira-Nunes","year":"2020","journal-title":"Biochim. Biophys. Acta"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279725000237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279725000237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T12:29:52Z","timestamp":1740400192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279725000237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":52,"alternative-id":["S0009279725000237"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2025.111393","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostate cancer-selective anticancer action of an oxindole derivative via HO-1-mediated disruption of metabolic reprogramming","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2025.111393","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111393"}}